Therapeutics Advances
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Jan 25, 2016; 8(2): 40-55
Published online Jan 25, 2016. doi: 10.4253/wjge.v8.i2.40
Table 1 Indications for colorectal endoscopic submucosal dissection (Japan Gastroenterological Endoscopy Society)
Lesions for which endoscopic en bloc resection is required
(1) Lesions for which en bloc resection with snare EMR is difficult to apply
LST-NG, particularly LST-NG pseudo-depressed type
Lesions showing a Vi-type pit pattern
Carcinoma with shallow T1 submucosal invasion
Large depressed-type tumors
Large protruded-type lesions suspected to be carcinoma. Including LST- G, nodular mixed type
(2) Mucosal tumors with submucosal fibrosis as a result of a previous biopsy or prolapse caused by intestinal peristalsis
(3) Sporadic localized tumors in conditions of chronic inflammation such as ulcerative colitis
(4) Local residual or recurrent early carcinomas after endoscopic resection
Table 2 Colorectal endoscopic submucosal dissection outcomes for epithelial neoplasms in Asian studies
Ref.Patients, n(% rectal)Study designEnrollmentperiodSize(mm)Time(min)En bloc(%)R0(%)Perforationrate(%)Delayedbleeding(%)Hospitalstay(d)Follow-up
Fujishiro et al[63], 200635 (100)ProspectiveFeb 2001 Feb 200532.8NS88.662.95.728.6-Missing rate: n = 0; 0% Mean: 36 mo (12-60) Recurrence rate at 2 mo: 2.8% 31/32 (96.8%) recurrence-free at 3 yr
Tamegai et al[64], 200771 (23.9)NSJan 2003 Dec 200532.761.198.695.6NS1.4-Missing rate: n = 7; 9.86% Mean: 12.2 mo (range 3-34) Recurrences: 0%
Hurlstone et al[70], 200742 (33.3)ProspectiveMar 2004 Aug 2006314878.673.82.42.422Missing rate: n = 6; 14.3% Median: 6 mo (range: 3-18) Recurrences 4/36 (11%) Curative resections at 6 mo: 34/42 (81%)
Fujishiro et al[112], 2007200 (26)NSJul 2000 Mar 200629.9-91.570.560.5-Median: 18 mo (range 12-60) Recurrences: 1.8%
Saito et al[65], 2007200 (30.5)NSOct 2003 Jul 200635908470525Median: 7 mo Missing rate: 10% Recurrences: 0.5%
Tanaka et al[68], 200770 (48.6)NS< Dec 20052870.580-101.4-In curative resections, 0% recurrence rate Other information not provided
Zhou et al[113], 200974 (56.7)NSJul 2006 Dec 200732.611093.289.28.11.4-Missing rate: n = 0; 0% Median: 14.3 mo (range 3-22) Recurrences: 0%
Isomoto et al[114], 2009292 (26.7)NSMay 2001 Dec 200826.8-90.179.87.90.7-Missing rate: 24.6% Median: 33 mo in R0 36 mo in non-R0 resections R0: 0% recurrences 1 recurrence in non-R0 resections
Saito et al[115], 2009405 (27.4)NSNS409086.9-3.51-Mean ± SD: 20 ± 13 mo 2% recurrences
Iizuka et al[62], 200944 (59)RetrospectiveJan 2000 Dec 20043911061588---
Niimi et al[60], 2010310 (26.1)Retrospective MonocentricJul 2000 Dec 200828.9-90.374.54.81.3-Median: 38.7 mo (12.8-104.2) 2% recurrences 3-yr overall/disease-specific survivals: 97.1%/100% 5-yr overall/disease-specific survivals: 95.3%/100% 8 died of other coexisting diseases 0 died of CRC
Yoshida et al[116], 2010250 (31.6)NSApr 2005 Mar 201029.610686.881.262.4--
Saito et al[81], 2010145 (50.3)RetrospectiveJan 2003 Dec 20063710884-6.21.4-Median: 20 mo 2.1% recurrences
Hotta et al[38], 2010120 (27.5)NSJun 2003 Sep 2008> 3014193.3857.5---
Saito et al[12], 20101111 (30.3)Multicentric ProspectiveJun 1998 Feb 20083511688895.31.5--
Toyonaga et al[117], 2010268 (25.7)RetrospectiveMay 2002 May 200740.364.599.298.12.20.37-Median: 32.2 mo (6.5-85.2) Follow-up: 227 out of the 241 curative resections (94.2%) Missing rate: 5.8% Recurrences: 0%
Matsumoto et al[118], 2010203 (NS)NSNov 2002 Jun 200933-85.7-6.9---
Uraoka et al[119], 2011202 (32.7)NSApr 2006 Mar 201040-91.687.12.40.5-Median: 11.4 mo Missing rate: 14% 0% disease specific mortality 1.5% overall mortality
Shono et al[61], 2011137 (26.2)NSApr 2007 Oct 201029.279.289.185.43.63.6-0% recurrences No other information provided
Kim et al[120], 2011108 (44)RetrospectiveMar 2007 Feb 200927.661.9-78.720.4---
Lee et al[84], 2012314 (19.1)RetrospectiveJan 2004 Nov 200928.954.792.787.680.643.6-
Lee et al[121], 2012499 (18.1)RetrospectiveOct 2006 Nov 201028.961.395-7.4-3.6-
Hisabe et al[122], 2012200 (30)NSJun 2003 Jun 201132.7108.986-71--
Saito et al[123], 20121321 (25.6)Multicentric-34.29095.487.22.92.5--
Okamoto et al[71], 201330 (50)NSDec 2010 Aug 20123661-10000--
Lee et al[72], 2013874 (20.7)Retrospective> Oct 200626.553.897.190.56.10.53.5-
Nakajima et al[80], 2013816 (36.3)Prospective MulticentricOct 2007 Dec 201039.49694.590.622.2--
Nawata et al[124], 2014150 (20.6)Retrospective 2 groups: A < 50 mm/B ≥ 50 mmApr 2010 Jul 201326/5938/8698.797.300--
Sakamoto et al[66], 2014164 (38)RetrospectiveApr 2005 Mar 20123095959243--
Saito et al[109], 2014900 (NS)NSNS4010091872.71.7--
Lee et al[125], 2015173 (24.3)RetrospectiveJan 2010 Dec 201325.95-88.481.5113.4--
Rahmi et al[67], 201528 (25)Retrospective 100% recurrencesDec 2008 Jul 201317.56396.492.93.507Median: 22 mo Missing rate: 35.7% Recurrences: 0%
Table 3 Colorectal endoscopic submucosal dissection outcomes for epithelial neoplasms in European studies
Ref.Patients, n (% rectal)Study designEnrollment periodSize (mm)Time (min)En bloc (%)R0 (%)Perforation rate (%)Delayed bleeding (%)Hospital stay (d)Follow-up
Farhat et al[16], 201185 (84.7)ProspectiveJan 2008 Aug 2010--6762.3----
Probst et al[14], 201276 (86.6)NSOct 2004 Sep 201145.817681.669.76.610.5-Median: 23.6 mo (2-83) Included in follow-up: n = 65 9.2% residual neoplasms (5 piecemeal and 1 en bloc R1 lateral)
Repici et al[20], 201340 (100)ProspectiveApr 2010 Jan 201146.886.1908052.5-Recurrences: 2.5%
Thorlacius et al[126], 201329 (59)NSJan 2012 Mar 20132814272696.90-Recurrences: 0% at 3-6 mo Missing rate: 82.7%
Spychalski et al[127], 201570 (56)NSJun 2013 Jun 20143011066-86-Missing rate: 14.6% Recurrences: 4.9% Follow-up < 12 mo
Rahmi et al[128], 201445 (100)NSFeb 2010 Jun 201235110645318133.4For curative resections at 12 mo: 88%
Bialek et al[129], 201437 (67.6)Prospective2007 2013377086.581.105.7-At 1-yr follow-up: 1.7% recurrences